1-2 of 2
Achim Heinecke, Ph.D.
Close
Sort by
Journal Articles

Outcome of Myelodysplastic Syndrome Treated with Intensive Chemotherapy within the AMLCG99 Trial

Utz Krug, MD, Carsten Muller-Tidow, MD, Matthias Stelljes, Maria Cristina Sauerland, MSc, Achim Heinecke, Ph.D., Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Jan Braess, MD, Karsten Spiekermann, MD, Sarah Volpert, PhD, Peter Staib, Andreas Grüneisen, MD, Wolfgang Kern, MD, Albrecht Reichle, MD, Wolf-Dieter Ludwig, Leopold Balleisen, MD, Hartmut Eimermacher, MD, Carlo Aul, MD, Herbert Rasche, MD, Eva Lengfelder, MD, Eckhard Thiel, Joachim Kienast, Hubert Serve, MD, Bernhard Josef Woermann, MD, Wolfgang Hiddemann, MD, Wolfgang E. Berdel, Thomas Buchner, MD
Journal: Blood
Blood (2011) 118 (21): 2773.
https://doi.org/10.1182/blood.V118.21.2773.2773
Published: 2011
Journal Articles

Estimating the Chances of Older AML Patients to Achieve a Complete Remission Upon Intensive Induction Chemotherapy - An AMLCG and SAL Study

Utz O Krug, MD, Christian Rohde, Ph.D., Achim Heinecke, Ph.D., Maria Cristina Sauerland, Anja Koschmieder, Christoph Röllig, Markus Schaich, MD, Christian Thiede, Michael Kramer, Jan Braess, M.D., Karsten Spiekermann, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Gerhard Ehninger, Prof., Bernhard Josef Woermann, MD, Wolfgang E. Berdel, Wolfgang Hiddemann, MD, Thomas Buchner, Carsten Müller-Tidow
Journal: Blood
Blood (2010) 116 (21): 2696.
https://doi.org/10.1182/blood.V116.21.2696.2696
Published: 2010